- Oral intake of curcumin with piperine reduce the morbidity and mortality in COVID-19 patients: a randomized controlled trial
This double-blind, randomized and controlled trial aimed to determine the effects of curcumin administered with piperine (to optimize absorption) on symptoms of patients with COVID-19 in addition to conventional treatment. Subjects received curcumin (525 mg) with piperine (2.5 mg) in tablet form (intervention group) or probiotics (control group) twice a day. Results revealed that curcumin ...
- Virgin coconut oil is effective in lowering C-reactive protein levels among suspect cases of COVID-19
This 28-day randomized, double-blind and controlled trial aimed to determine whether virgin coconut oil (VCO) could be used as an adjunct prophylaxis to prevent the progression of symptoms among suspect or probable cases of COVID-19 (n = 63 adults) in isolation facilities. The participants received either a standardized meal (control) or a standardized meal mixed ...
- Dietary supplements have modest but significant effects on COVID-19 infections
Food supplements can be included in the various approaches for the management of COVID-19 infections. However, evidences are scarce, and this study investigated the potential preventive effects of food supplements on COVID-19 infections.
445850 subscribers of an app aiming to self-report information related to COVID-19 have been followed.
Results showed that in participants from UK (372720 subjects), ...
- Interest of botanicals for COVID-19
Nutritional supplements, TaibUVID (each dose contained 2g nigella sativa, 1g chamomile and 10 ml natural honey) and TaibUVID Forte (adds 1g fennel, 0.5 gram costus, 0.5 gram senna to TaibUVID), were suggested as a adjuvants for COVID-19 contacts, patients and public prophylaxis. A retrospective study was conducted in Egypt (n=20). 65% of COVID-19 patients (n ...
- Neem (Azadirachta indica) may reduce the risk of COVID-19 infection
This pilot study, double-blinded, placebo-controlled and randomized, examined the prophylactic effect of neem in patients at risk of COVID-19 infection due to contact with COVID-19 positive patients. 190 participants have been enrolled. They received a placebo or 50 mg twice daily of a neem leaf extract for 28 days.
Among the 154 participants who completed the ...
- Omega 3 fatty acids in patients infected by COVID-19
In this double-blind, randomized clinical trial, 128 critically ill patients (35-85 years) infected with COVID-19 have been randomly assigned to the intervention (fortified formula with omega 3 fatty acids) (n = 42) and control (n = 86) groups during 14 days. The intervention group received one capsule of 1000 mg omega-3 daily containing 400 mg ...
- Evaluation of the recognized active compounds for COVID-19: two studies on EGCG from green tea and crocin from saffron
Researchers continue to examine the potential effectiveness of botanicals and their active compounds for the management of CODIV-19 infection. Recently, two studies have provided data on the potential efficacy of two well-known compounds.
Park et al. (2021) have published an article on the therapeutic potential of EGCG, the major green tea polyphenol. Several studies have demonstrated ...
- Melatonin may reduce the risk of infection with COVID-19 and other RNA viruses
A preprint article reports that melatonin exposure after intubation in patients with positive diagnosis to COVID-19 is statistically associated with a positive outcomes (Ramlall et al., 2020).
Following these results, another recent article tried to summarize the potential effect of melatonin on RNA viral infections, including COVID-19 (DiNicolantonio et al., 2021).
Mechanisms are quite complex, but ...
- Dietary supplements and nutraceuticals for COVID-19 prevention and treatment
The year 2020 saw scientists and the medical community scrambling to repurpose or discover novel host-directed therapies against the coronavirus diseases 2019 (COVID-19) pandemic caused by the spread of the novel Severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2).
This rapid effort led to the identification of some promising pharmaceutical therapies for hospitalized patients, such as ...
- Ginkgo Biloba for influenza and coronavirus COVID-19 infections
This review refers to the roles of Ginkgo Biloba to reduce the risk of infection in the respiratory tract, notably COVID-19 and influenza, and the potential mechanisms of action.
Ginkgo Biloba contains quercetin and other constituents, which have anti-inflammatory and immune modulator effects by reducing pro-inflammatory cytokines concentrations. Ginkgolic acid (GA) can inhibit the fusion ...
